Key facts
- Gleamer’s last known valuation is $52.1M (Jul 2023).
- It has raised $39.5M; the latest was Merger/Acquisition in Mar 2026.
- Notable investors include Bpifrance, Kima Ventures, La French Tech, Agoranov, UI Investissement — 21 tracked in total.
- Status: Acquired/Merged (Operating Subsidiary).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Gleamer
- ·The full record, as it builds
Funding rounds
No funding rounds for Gleamer are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gleamer
Developer of a radiology technology designed to detect and highlight bone abnormalities. The company's technology utilizes an artificial intelligence-based assistant that is easy to use, automatically detects lesions on trauma X-rays and provides preliminary data for diagnosis on standard radiography, enabling radiologists to avoid missing tiny lesions and prioritize patients.
- Sector
- Healthcare
- HQ
- Saint-Mandé, France
- Founded
- 2017
- Employees
- 130
- Website
- gleamer.ai/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Gleamer doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gleamer shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gleamer in its N-PORT filings yet. We sweep new filings monthly.